Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Casi Pharmaceuticals Inc (CASI)  
$1.63 0.00 (0.00%) as of 4:30 Mon 3/20


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 123,940,000
Market Cap: 202.02(M)
Last Volume: 38,851 Avg Vol: 19,828
52 Week Range: $1.63 - $1.63
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CASI Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China, the U.S., and throughout the world.. In China, Co.'s first commercial product, EVOMELA® is approved for use as a conditioning treatment prior to stem cell transplantation and as a palliative treatment for patients with multiple myeloma. The other core hematology/oncology assets in our pipeline include: CNCT19, which is being developed as a potential treatment for patients with hematological malignancies which express CD19 including, B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 371,517
Total Buy Value $0 $0 $0 $1,315,104
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 11
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 159
  Page 6 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Tarnow Michael M Director   –       •      –    2006-06-15 4 A $0.00 $0 D/D 16,025 35,663     -
   Knight Peter S Director   –       •      –    2006-06-15 4 A $0.00 $0 D/D 16,025 40,216     -
   Randall Mark C M Director   –       •      –    2006-06-15 4 A $0.00 $0 D/D 16,025 40,216     -
   Burns James S President and CEO   •       •      –    2006-06-12 4 B $1.58 $7,900 D/D 5,000 70,000 2.81     -
   Bush Dwight L Director   –       •      –    2005-07-28 4 A $0.00 $0 D/D 8,064 24,191     -
   Tarnow Michael M Director   –       •      –    2005-07-28 4 A $0.00 $0 D/D 8,064 24,191     -
   Hunter Cevera Jennie Director   –       •      –    2005-07-28 4 A $0.00 $0 D/D 8,064 24,191     -
   Randall Mark C M Director   –       •      –    2005-07-28 4 A $0.00 $0 D/D 8,064 24,191     -
   Brooks Donald S Director   –       •      –    2005-07-28 4 A $0.00 $0 D/D 8,064 24,191     -
   Knight Peter S Director   –       •      –    2005-07-28 4 A $0.00 $0 D/D 8,064 24,191     -
   Cape Ronald Director   –       •      –    2005-07-28 4 A $0.00 $0 D/D 8,064 24,191     -
   Burns James S President and CEO   •       –      –    2005-04-06 4 B $2.35 $35,595 D/D 15,000 65,000 2.74     -
   Celgene Corp /de/ 10% Owner   –       –       •   2005-03-31 4 OE $1.50 $10,500,000 D/D 7,000,000 23,750,000     -
   Burns James S President and CEO   •       –      –    2005-01-10 4/A B $3.68 $1,840 D/D 500 50,000 2.66     -
   Burns James S President and CEO   •       –      –    2005-01-10 4 B $3.63 $52,907 D/D 14,500 49,500 2.74     -
   Burns James S President and CEO   •       –      –    2004-09-24 4 B $1.66 $16,944 D/D 10,000 35,000 2.74     -
   Klein Udo Senior Vice President of R&D   •       –      –    2004-09-03 4 B $1.49 $2,682 D/D 1,800 1,800 2.66     -
   Sidor Carolyn F Corp. VP and Chief Med. OfcrOf   •       –      –    2004-09-01 3 IO $0.00 $0 D/D 0 1,000     -
   Burns James S President and CEO   •       –      –    2004-07-14 4 B $1.92 $49,118 D/D 25,000 25,000 2.74     -
   Saglio Dane R Chief Financial Officer   •       –      –    2004-07-14 4 A $1.95 $3,900 D/D 2,000 2,300     -
   Bush Dwight L Director   –       •      –    2004-06-16 4 A $2.16 $25,000 D/D 11,574 16,127     -
   Tarnow Michael M Director   –       •      –    2004-06-16 4 A $2.16 $25,000 D/D 11,574 16,127     -
   Hunter Cevera Jennie Director   –       •      –    2004-06-16 4 A $2.16 $25,000 D/D 11,574 16,127     -
   Cape Ronald Director   –       •      –    2004-06-16 4 A $2.16 $25,000 D/D 11,574 16,127     -
   Randall Mark C M Director   –       •      –    2004-06-16 4 A $2.16 $25,000 D/D 11,574 16,127     -

  159 Records found
  1  2  3  4  5  6  7   
  Page 6 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed